Rare Inflammatory Disease Treatment Market by Indication (Ulcerative Colitis, Juvenile Rheumatoid Arthritis, Psoriatic Arthritis and Other Indications), Drug Class (Biologics and Organic Compounds), Mode of Administration (Injectable, Oral and Others), Distribution Channel and Region Forecast- 2022-2028
Market Insights on Rare Inflammatory Disease Treatment covering sales outlook, demand forecast and up-to-date key trends
Rare Inflammatory Disease Treatment Market Outlook (2022-2028)
[170 Pages Report] The Rare Inflammatory Disease Treatment Market has garnered a market value of US$ 12,664 Mn in 2021, anticipated to register a positive CAGR of 4.6% in the forecast period 2022-2028 and reach a value of US$ 17,335.8 Mn.
Increasing investment in R&D for various drug developments and increasing demand for different modes of drug administration have further boosted the market demand for various rare inflammatory diseases treatments.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
How The Market Progressed Till June 2022?
Particulars
Details
H1, 2021
8.35%
H1, 2022 Projected
8.82%
H1, 2022 Outlook
8.52%
BPS Change - H1, 2022 (O) – H1, 2022 (P)
(-) 30 ↓
BPS Change – H1, 2022 (O) – H1, 2021
(+) 17 ↑
A comparative analysis related to the market growth rates and development prospects in the global rare inflammatory disease treatment market is presented by Future Market Insights. The market is highly influenced by the onerous regulatory environment and innovation factors for orphan drugs under the impact of macro and industry factors.
According to Future Market Insights analysis, the global rare inflammatory disease treatment market expects to surge by 17 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. Whereas in comparison to H1-2022 projected value, the market during H1-2022 outlook period will show a dip of 30 BPS.
The market change in the BPS is associated with the extensive process of orphan drug approval by regulatory bodies for licensure and distribution. Further, revision in molecular portfolio for existing products also face a backlash in terms of patent renewal, owed to the emergence of several clinically viable alternatives to existing solutions.
This has caused a reduction in the BPS value. Additionally, the growth of the biopharmaceutical industry upon the advent of the COVID-19 pandemic has provided a boost in the BPS value change for the market.
The market is subject to activities such as supporting the treatment of rare diseases through collaborative activities, revenue fluidity which arises from product Medicaid rebates, chargebacks due to other government programs, and existing patented product portfolio.
Industry Analysis of Rare Inflammatory Disease Treatment (2013 to 2021) Vs Market Estimates (2022 to 2028)
From 2013 to 2021, treatment for rare inflammatory diseases experienced an increase of 3.8% in value CAGR terms. Various distribution channels such as hospital pharmacies, retail pharmacies, and online pharmacies have observed high demand for treating several rare inflammatory diseases. Recent outbreaks of infectious diseases, such as COVID-19, have increased market demand to a major extent.
During the height of the pandemic crisis, clinicians, doctors and other healthcare stakeholders extensively relied on anti-inflammatory drugs to ease complications experienced by severely infected and immunocompromised patients. Drugs such as ibuprofen, for instance, was cleared by the National Health Service in the U.K to be used as a nonsteroidal anti-inflammatory drug (NSAID) to inhibit receptors responsible for triggering an inflammatory response to the coronavirus.
Companies have been considering in their production processes ways to improve the treatment of rare inflammatory diseases, such as eosinophilic granulomatosis with polyangiitis (EGPA), a rare disorder that causes vasculitis. One such treatment is Nucala, a medication for patients aged 6 years or older with relapsing-remitting or refractory EGPA. Likewise, several orphan drugs are coming into the limelight for numerous rare inflammatory diseases. Overall, demand for rare inflammatory disease treatment is anticipated to rise at a CAGR of around 4.6% through 2028.
How is the Rising Incidence of Inflammatory & Autoimmune Diseases Generating Opportunities for New Therapies?
Healthcare experts have associated cytokine IL-23 with treatment of inflammatory and autoimmune diseases. Researchers have identified a fundamental molecular mechanism essential to inflammatory and autoimmune diseases such as multiple sclerosis, rheumatoid arthritis and psoriasis. The action of pro-inflammatory cytokine IL-23, depends on the organizational stimulation of its receptor, namely IL-23R.
Moreover, the occurrence of inflammatory and autoimmune diseases is increasing at a rapid pace. According to the World Health Organization, psoriasis affects approximately 100 million people globally, while between 1.3% and 34.7% develop chronic and inflammatory arthritis. Likewise, inflammatory bowel infections such as ulcerative colitis and Crohn’s disease are increasing at an alarming rate in formerly unaffected fragments of the world.
Hence, medical practitioners are introducing several drug candidates to address some of the most debilitating rare inflammatory diseases. In 2018, for instance, the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) granted an extension of indication to Kineret (anakinra) for treating Still's disease. Kineret is an immunosuppressive medicine which inhibits chemical messenger activity of interleukin-1, an agent which is produced in excess amongst patients suffering from rheumatoid arthritis and juvenile idiopathic arthritis.
Find your sweet spots for generating winning opportunities in this market.
Region-wise Analysis
High Prevalence Rate amongst Adults & Children Broadening Prospects in North America?
FMI forecasts the rare inflammatory disease treatment industry in North America to accumulate a market share of 39.9% in 2022. The presence of a well-developed health care system and several reimbursement programs aimed at facilitating access to treatment for those with rare illnesses are among the chief growth drivers.
More than 30 million Americans are afflicted with rare diseases. Every year, approximately 6,200 Americans are affected diseases, including Polycythemia Vera, while juvenile rheumatoid arthritis is one of the most common types of arthritic diseases that children are diagnosed with in the United States.
Demand for rare inflammatory disease treatment has risen through various distribution channels including hospital pharmacies, retail pharmacies, and online pharmacies. As a result, the U.S. is expected to account for the largest market share in the market for rare inflammatory diseases treatment.
How is Discovery of New Add-On Treatments Facilitating Expansion in Europe?
D of new treatments and advancements in medical technology have driven market demand for rare inflammatory disease treatment throughout Europe. With increasing investments in open-source drug delivery systems and evaluations of their effectiveness in treating rare diseases, more treatment options are becoming available for rare inflammatory diseases.
Recently, in September 2021, the European Medicines Agency has recommended granting an extension of indication to Nucala (mepolizumab) as an add-on treatment for patients aged 6 years and older with relapsing-remitting or refractory eosinophilic granulomatosis with polyangiitis (EGPA), responsible for inflaming vital organs such as the lungs, heart, skin, nervous system and gastrointestinal tract.
It is estimated that between 0.18 and 4 new cases per 1 million are diagnosed each year with EGPA. The drug is already approved for treating patients of the same age group for eosinophilic asthma. According to FMI, rare inflammatory disease treatment in Europe is like to accumulate a market share of 24% in 2022.
Will Ulcerative Colitis Spearhead Rare Inflammatory Disease Treatment Demand?
Due to the significant cost savings associated with ulcerative colitis treatments, the producers will be influenced to increase their manufacturing capacities for advanced drugs and therapies in the future.
Technological advancements and the increasing number of patients suffering from ulcerative colitis have contributed to the development of advanced treatments for ulcerative colitis. The influx of new therapeutics methods, demand for enhancing drugs, and advances in treating ulcerative colitis have propelled market demand for rare inflammatory diseases treatments.
Why are Retail Pharmacies Emerging as the Primary POC for Availing Rare Inflammatory Disease Treatment Drugs?
The growing prevalence of diseases and demand for 24/7 medication sales have catalyzed the global market demand for drugs at retail pharmacies. Future growth in artificial intelligence, advanced analytics, and other technologies will help drive the retail pharmacy market in the global market.
Health and wellness services are the key drivers of customer satisfaction at brick-and-mortar pharmacies. These services score 66 points higher than other types of services. Pharmacies with these services are present in 86% of chain pharmacies, 83% of supermarkets, and 75% of mass merchandisers.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Prominent treatment providers are emphasizing on advancing drug and treatment offerings by initiating a series of clinical studies as well as forging collaborative and acquisition agreements with existing pharmaceutical companies.
In December 2021, Pfizer Inc. announced that it had reached a definitive agreement to acquire Arena Pharmaceuticals Inc., which is developing innovative possible treatments for a variety of immuno-inflammatory diseases. The proposed acquisition offers best-in-class treatment to address unmet clinical needs for more patients with immuno-inflammatory diseases
Likewise, in November 2021, Regeneron Pharmaceuticals Inc. announced additional positive results from a Phase 3 trial run jointly with NIAID on the use of single dose of investigational REGEN-COV® 1,200 mg sub-cutaneous injections. The findings revealed that the drug successfully protects healthy individuals from contracting COVID-19 with a success rate of 81.6%
Rare Inflammatory Disease Treatment Report Scope
Attribute
Details
Forecast Period
2022-2028
Historical Data Available for
2013-2021
Market Analysis
US$ Million for Value
Key Regions Covered
North America
Latin America
Europe
Asia Pacific
Middle East & Africa (MEA)
Key Countries Covered
USA
Canada
Brazil
Mexico
Germany
UK
France
Spain
Italy
China
Japan
India
Malaysia
Singapore
Australia
New Zealand
Israel
South Africa
GCC
Key Market Segments Covered
Indication
Drug Class
Mode of Administration
Distribution Channel
Key Companies Profiled
Novartis AG
Abbvie Inc.
Abbott Laboratories
Regeneron Pharmaceuticals Inc.
Swedish Orphan Biovitrum AB
Pfizer, Inc.
Valeant Pharmaceuticals International Inc. (Bausch Health)
Mallinckrodt Plc.
Johnson & Johnson
Pricing
Available upon Request
Key Segments Covered in Rare Inflammatory Disease Treatment Industry Survey
Rare Inflammatory Disease Treatment by Indication
RID Treatment for Ulcerative Colitis
RID Treatment Juvenile Rheumatoid Arthritis
RID Treatment Psoriatic Arthritis
RID Treatment Other Indications
Rare Inflammatory Disease Treatment by Drug Class
Biologics-based RID Treatment
Organic Compounds-based RID Treatment
Rare Inflammatory Disease Treatment by Mode of Administration
RID Injectables
Oral RID Treatment
Other RID Treatment Administration Modes
Rare Inflammatory Disease Treatment by Distribution Channel
RID Treatment through Hospital Pharmacies
RID Treatment through Retail Pharmacies
RID Treatment through Online Pharmacies
Rare Inflammatory Disease Treatment Market by Region
North America RID Treatment Market
Latin America RID Treatment Market
Europe RID Treatment Market
Asia Pacific RID Treatment Market
Middle East & Africa (MEA)
Frequently Asked Questions
In 2022, the global rare inflammatory disease treatment market is set to be net US$ 13,249.2 Mn.
FMI Analysts predict the rare inflammatory disease treatment market to attain an estimated worth of US$ 17,335.8 Mn by 2028
North America will hold the highest global market share of 39.9% in 2022
The rare inflammatory disease treatment industry to rise at a CAGR of 4.6% from 2022 to 2028
Table of Content
1. Global Economic Outlook2. Global Rare Inflammatory Disease Treatment Market - Executive Summary3. Global Rare Inflammatory Disease Treatment Market Overview
3.1. Introduction
3.1.1. Global Rare Inflammatory Disease Treatment Market Taxonomy
3.1.2. Global Rare Inflammatory Disease Treatment Market Definition
3.2. Global Rare Inflammatory Disease Treatment Market Size (US$ Mn) and Forecast, 2013-2028
3.2.1. Global Rare Inflammatory Disease Treatment Market Y-o-Y Growth
3.3. Global Rare Inflammatory Disease Treatment Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. Pricing Analysis
3.7. Forecast Scenario
3.8. Parent Market Overview
3.9. PEST Analysis
3.10. Porter's Five Forces Analysis
3.11. Key Regulations
3.11.1. Key Regulations - North America
3.11.2. Key Regulations - Latin America
3.11.3. Key Regulations - Europe
3.11.4. Key Regulations - Asia Pacific
3.11.5. Key Regulations - Middle East & Africa
3.12. Product Approvals in Rare Inflammatory Disease Treatment Market
3.13. Investment Feasibility Index
3.14. Market Competition Structure
3.15. Market Positioning and Behaviour Assessment
3.16. List of Distributors
3.17. Key Participants Market Presence (Intensity Map) By Region
4. Global Rare Inflammatory Disease Treatment Market Analysis and Forecast 2013-2028
4.1. Global Rare Inflammatory Disease Treatment Market Size and Forecast By Indication, 2013-2028
4.1.1. Ulcerative Colitis Market Size and Forecast, 2013-2028
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Juvenile Rheumatoid Arthritis Market Size and Forecast, 2013-2028
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Psoriatic Arthritis Market Size and Forecast, 2013-2028
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
4.1.4. Other Indications Market Size and Forecast, 2013-2028
4.1.4.1. Revenue (US$ Mn) Comparison, By Region
4.1.4.2. Market Share Comparison, By Region
4.1.4.3. Y-o-Y growth Comparison, By Region
4.2. Global Rare Inflammatory Disease Treatment Market Size and Forecast By Drug Class, 2013-2028
4.2.1. Biologics Market Size and Forecast, 2013-2028
4.2.1.1. Revenue (US$ Mn) Comparison, By Region
4.2.1.2. Market Share Comparison, By Region
4.2.1.3. Y-o-Y growth Comparison, By Region
4.2.2. Organic Compounds Market Size and Forecast, 2013-2028
4.2.2.1. Revenue (US$ Mn) Comparison, By Region
4.2.2.2. Market Share Comparison, By Region
4.2.2.3. Y-o-Y growth Comparison, By Region
4.3. Global Rare Inflammatory Disease Treatment Market Size and Forecast By Mode of Administration, 2013-2028
4.3.1. Injectables Market Size and Forecast, 2013-2028
4.3.1.1. Revenue (US$ Mn) Comparison, By Region
4.3.1.2. Market Share Comparison, By Region
4.3.1.3. Y-o-Y growth Comparison, By Region
4.3.2. Oral Market Size and Forecast, 2013-2028
4.3.2.1. Revenue (US$ Mn) Comparison, By Region
4.3.2.2. Market Share Comparison, By Region
4.3.2.3. Y-o-Y growth Comparison, By Region
4.3.3. Others Market Size and Forecast, 2013-2028
4.3.3.1. Revenue (US$ Mn) Comparison, By Region
4.3.3.2. Market Share Comparison, By Region
4.3.3.3. Y-o-Y growth Comparison, By Region
4.4. Global Rare Inflammatory Disease Treatment Market Size and Forecast By Distribution Channel, 2013-2028
4.4.1. Hospital Pharmacies Market Size and Forecast, 2013-2028
4.4.1.1. Revenue (US$ Mn) Comparison, By Region
4.4.1.2. Market Share Comparison, By Region
4.4.1.3. Y-o-Y growth Comparison, By Region
4.4.2. Retail Pharmacies Market Size and Forecast, 2013-2028
4.4.2.1. Revenue (US$ Mn) Comparison, By Region
4.4.2.2. Market Share Comparison, By Region
4.4.2.3. Y-o-Y growth Comparison, By Region
4.4.4. Market Size and Forecast, 2013-2028
4.4.4.1. Revenue (US$ Mn) Comparison, By Region
4.4.4.2. Market Share Comparison, By Region
4.4.4.3. Y-o-Y growth Comparison, By Region
5. North America Rare Inflammatory Disease Treatment Market Size and Forecast, 2013-2028
5.1. North America Outlook
5.2. North America Parent Market Outlook
5.3. North America Target Market Outlook
5.4. Revenue (US$ Mn) Comparison, By Country
5.4.1. US Market Size and Forecast (US$ Mn), 2013-2028
5.4.2. Canada Market Size and Forecast (US$ Mn), 2013-2028
5.5. Revenue (US$ Mn) Comparison, By Indication
5.6. Revenue (US$ Mn) Comparison, By Drug Class
5.7. Revenue (US$ Mn) Comparison, By Mode of Administration
5.8. Revenue (US$ Mn) Comparison, By Distribution Channel
6. Latin America Rare Inflammatory Disease Treatment Market Size and Forecast, 2013-2028
6.1. Latin America Outlook
6.2. Latin America Parent Market Outlook
6.3. Latin America Target Market Outlook
6.4. Revenue (US$ Mn) Comparison, By Country
6.4.1. Brazil Market Size and Forecast (US$ Mn), 2013-2028
6.4.2. Mexico Market Size and Forecast (US$ Mn), 2013-2028
6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2013-2028
6.5. Revenue (US$ Mn) Comparison, By Indication
6.6. Revenue (US$ Mn) Comparison, By Drug Class
6.7. Revenue (US$ Mn) Comparison, By Mode of Administration
6.8. Revenue (US$ Mn) Comparison, By Distribution Channel
7. Europe Rare Inflammatory Disease Treatment Market Size and Forecast, 2013-2028
7.1. Europe Outlook
7.2. Europe Parent Market Outlook
7.3. Europe Target Market Outlook
7.4. Revenue (US$ Mn) Comparison, By Country
7.4.1. Germany Market Size and Forecast (US$ Mn), 2013-2028
7.4.2. U.K. Market Size and Forecast (US$ Mn), 2013-2028
7.4.3. Spain Market Size and Forecast (US$ Mn), 2013-2028
7.4.4. France Market Size and Forecast (US$ Mn), 2013-2028
7.4.5. Italy Market Size and Forecast (US$ Mn), 2013-2028
7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2013-2028
7.5. Revenue (US$ Mn) Comparison, By Indication
7.6. Revenue (US$ Mn) Comparison, By Drug Class
7.7. Revenue (US$ Mn) Comparison, By Mode of Administration
7.8. Revenue (US$ Mn) Comparison, By Distribution Channel
8. Japan Rare Inflammatory Disease Treatment Market Size and Forecast, 2013-2028
8.1. Japan Outlook
8.2. Japan Parent Market Outlook
8.3. Japan Target Market Outlook
8.4. Japan Market Size and Forecast (US$ Mn), 2013-2028
8.5. Revenue (US$ Mn) Comparison, By Indication
8.6. Revenue (US$ Mn) Comparison, By Drug Class
8.7. Revenue (US$ Mn) Comparison, By Mode of Administration
8.8. Revenue (US$ Mn) Comparison, By Distribution Channel
9. APEJ Rare Inflammatory Disease Treatment Market Size and Forecast, 2013-2028
9.1. APEJ Outlook
9.2. APEJ Parent Market Outlook
9.3. APEJ Target Market Outlook
9.4. Revenue (US$ Mn) Comparison, By Country
9.4.1. China Market Size and Forecast (US$ Mn), 2013-2028
9.4.2. India Market Size and Forecast (US$ Mn), 2013-2028
9.4.3. Malaysia Market Size and Forecast (US$ Mn), 2013-2028
9.4.4. Singapore Market Size and Forecast (US$ Mn), 2013-2028
9.4.5. Australia Market Size and Forecast (US$ Mn), 2013-2028
9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2013-2028
9.5. Revenue (US$ Mn) Comparison, By Indication
9.6. Revenue (US$ Mn) Comparison, By Drug Class
9.7. Revenue (US$ Mn) Comparison, By Mode of Administration
9.8. Revenue (US$ Mn) Comparison, By Distribution Channel
10. MEA Rare Inflammatory Disease Treatment Market Size and Forecast, 2013-2028
10.1. MEA Outlook
10.2. MEA Parent Market Outlook
10.3. MEA Target Market Outlook
10.4. Revenue (US$ Mn) Comparison, By Country
10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2013-2028
10.4.2. South Africa Market Size and Forecast (US$ Mn), 2013-2028
10.4.3. Israel Market Size and Forecast (US$ Mn), 2013-2028
10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2013-2028
10.5. Revenue (US$ Mn) Comparison, By Indication
10.6. Revenue (US$ Mn) Comparison, By Drug Class
10.7. Revenue (US$ Mn) Comparison, By Mode of Administration
10.8. Revenue (US$ Mn) Comparison, By Distribution Channel
11. Global Rare Inflammatory Disease Treatment Market Company Share, Competition Landscape and Company Profiles
11.1. Global Rare Inflammatory Disease Treatment Market- Company Share Analysis
11.2. Global Rare Inflammatory Disease Treatment Market - Competition Landscape
11.3. Global Rare Inflammatory Disease Treatment Market - Company Profiles
11.3.1. Pfizer, Inc.
11.3.2. Novartis AG
11.3.3. Allergan Plc
11.3.4. Abbvie, Inc.
11.3.5. Valeant Pharmaceuticals International, Inc.
11.3.6. Abbott Laboratories
11.3.7. Johnson & Johnson
11.3.8. Regeneron Pharmaceuticals, Inc.
11.3.9. Mallinckrodt Plc
11.3.10. Swedish Orphan Biovitrum AB
12. Global Rare Inflammatory Disease Treatment Market - Key Takeaways13. Research Methodology14. Disclaimer
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
TABLE 1 Global Rare Inflammatory Disease Treatment Market Value (US$ Mn), 2013-2021
TABLE 2 Global Rare Inflammatory Disease Treatment Market Value (US$ Mn), 2022-2028
TABLE 3 Global Rare Inflammatory Disease Treatment Market Value (US$ Mn) and Y-o-Y, 2021-2028
TABLE 4 Global Ulcerative Colitis Segment Value (US$ Mn), By Region 2013-2021
TABLE 5 Global Ulcerative Colitis Segment Value (US$ Mn), By Region 2022-2028
TABLE 6 Global Ulcerative Colitis Segment Market Share, By Region 2013-2021
TABLE 7 Global Ulcerative Colitis Segment Market Share, By Region 2022-2028
TABLE 8 Global Ulcerative Colitis Segment Y-o-Y, By Region 2021-2028
TABLE 9 Global Juvenile Rheumatoid Arthritis Segment Value (US$ Mn), By Region 2013-2021
TABLE 10 Global Juvenile Rheumatoid Arthritis Segment Value (US$ Mn), By Region 2022-2028
TABLE 11 Global Juvenile Rheumatoid Arthritis Segment Market Share, By Region 2013-2021
TABLE 12 Global Juvenile Rheumatoid Arthritis Segment Market Share, By Region 2022-2028
TABLE 13 Global Juvenile Rheumatoid Arthritis Segment Y-o-Y, By Region 2021-2028
TABLE 14 Global Psoriatic Arthritis Segment Value (US$ Mn), By Region 2013-2021
TABLE 15 Global Psoriatic Arthritis Segment Value (US$ Mn), By Region 2022-2028
TABLE 16 Global Psoriatic Arthritis Segment Market Share, By Region 2013-2021
TABLE 17 Global Psoriatic Arthritis Segment Market Share, By Region 2022-2028
TABLE 18 Global Psoriatic Arthritis Segment Y-o-Y, By Region 2021-2028
TABLE 19 Global Other Indications Segment Value (US$ Mn), By Region 2013-2021
TABLE 20 Global Other Indications Segment Value (US$ Mn), By Region 2022-2028
TABLE 21 Global Other Indications Segment Market Share, By Region 2013-2021
TABLE 22 Global Other Indications Segment Market Share, By Region 2022-2028
TABLE 23 Global Other Indications Segment Y-o-Y, By Region 2021-2028
TABLE 24 Global Biologics Segment Value (US$ Mn), By Region 2013-2021
TABLE 25 Global Biologics Segment Value (US$ Mn), By Region 2022-2028
TABLE 26 Global Biologics Segment Market Share, By Region 2013-2021
TABLE 27 Global Biologics Segment Market Share, By Region 2022-2028
TABLE 28 Global Biologics Segment Y-o-Y, By Region 2021-2028
TABLE 29 Global Organic Compounds Segment Value (US$ Mn), By Region 2013-2021
TABLE 30 Global Organic Compounds Segment Value (US$ Mn), By Region 2022-2028
TABLE 31 Global Organic Compounds Segment Market Share, By Region 2013-2021
TABLE 32 Global Organic Compounds Segment Market Share, By Region 2022-2028
TABLE 33 Global Organic Compounds Segment Y-o-Y, By Region 2021-2028
TABLE 34 Global Injectables Segment Value (US$ Mn), By Region 2013-2021
TABLE 35 Global Injectables Segment Value (US$ Mn), By Region 2022-2028
TABLE 36 Global Injectables Segment Market Share, By Region 2013-2021
TABLE 37 Global Injectables Segment Market Share, By Region 2022-2028
TABLE 38 Global Injectables Segment Y-o-Y, By Region 2021-2028
TABLE 39 Global Oral Segment Value (US$ Mn), By Region 2013-2021
TABLE 40 Global Oral Segment Value (US$ Mn), By Region 2022-2028
TABLE 41 Global Oral Segment Market Share, By Region 2013-2021
TABLE 42 Global Oral Segment Market Share, By Region 2022-2028
TABLE 43 Global Oral Segment Y-o-Y, By Region 2021-2028
TABLE 44 Global Others Segment Value (US$ Mn), By Region 2013-2021
TABLE 45 Global Others Segment Value (US$ Mn), By Region 2022-2028
TABLE 46 Global Others Segment Market Share, By Region 2013-2021
TABLE 47 Global Others Segment Market Share, By Region 2022-2028
TABLE 48 Global Others Segment Y-o-Y, By Region 2021-2028
TABLE 49 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2013-2021
TABLE 50 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2022-2028
TABLE 51 Global Hospital Pharmacies Segment Market Share, By Region 2013-2021
TABLE 52 Global Hospital Pharmacies Segment Market Share, By Region 2022-2028
TABLE 53 Global Hospital Pharmacies Segment Y-o-Y, By Region 2021-2028
TABLE 54 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2013-2021
TABLE 55 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2022-2028
TABLE 56 Global Retail Pharmacies Segment Market Share, By Region 2013-2021
TABLE 57 Global Retail Pharmacies Segment Market Share, By Region 2022-2028
TABLE 58 Global Retail Pharmacies Segment Y-o-Y, By Region 2021-2028
TABLE 59 Global Online Pharmacies Segment Value (US$ Mn), By Region 2013-2021
TABLE 60 Global Online Pharmacies Segment Value (US$ Mn), By Region 2022-2028
TABLE 61 Global Online Pharmacies Segment Market Share, By Region 2013-2021
TABLE 62 Global Online Pharmacies Segment Market Share, By Region 2022-2028
TABLE 63 Global Online Pharmacies Segment Y-o-Y, By Region 2021-2028
TABLE 64 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2013-2021
TABLE 65 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2022-2028
TABLE 66 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2013-2021
TABLE 67 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2022-2028
TABLE 68 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2013-2021
TABLE 69 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2022-2028
TABLE 70 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2013-2021
TABLE 71 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2022-2028
TABLE 72 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2013-2021
TABLE 73 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2022-2028
TABLE 74 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2013-2021
TABLE 75 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2022-2028
TABLE 76 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2013-2021
TABLE 77 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2022-2028
TABLE 78 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2013-2021
TABLE 79 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2022-2028
TABLE 80 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2013-2021
TABLE 81 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2022-2028
TABLE 82 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2013-2021
TABLE 83 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2022-2028
TABLE 84 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2013-2021
TABLE 85 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2022-2028
TABLE 86 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2013-2021
TABLE 87 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2022-2028
TABLE 88 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2013-2021
TABLE 89 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2022-2028
TABLE 90 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2013-2021
TABLE 91 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2022-2028
TABLE 92 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2013-2021
TABLE 93 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2022-2028
TABLE 94 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2013-2021
TABLE 95 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2022-2028
TABLE 96 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2013-2021
TABLE 97 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2022-2028
TABLE 98 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2013-2021
TABLE 99 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2022-2028
TABLE 100 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2013-2021
TABLE 101 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2022-2028
TABLE 102 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2013-2021
TABLE 103 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2022-2028
TABLE 104 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2013-2021
TABLE 105 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2022-2028
TABLE 106 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2013-2021
TABLE 107 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2022-2028
TABLE 108 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2013-2021
TABLE 109 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2022-2028
TABLE 110 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2013-2021
TABLE 111 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2022-2028
TABLE 112 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2013-2021
TABLE 113 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2022-2028
TABLE 114 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2013-2021
TABLE 115 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2022-2028
TABLE 116 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2013-2021
TABLE 117 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2022-2028
TABLE 118 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2013-2021
TABLE 119 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2022-2028
TABLE 120 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2013-2021
TABLE 121 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2022-2028
TABLE 122 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2013-2021
TABLE 123 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2022-2028
Find your sweet spots for generating winning opportunities in this market.
List of Charts
FIG. 1 Global Rare Inflammatory Disease Treatment Market Value (US$ Mn), 2013-2021
FIG. 2 Global Rare Inflammatory Disease Treatment Market Value (US$ Mn) Forecast, 2022-2028
FIG. 3 Global Rare Inflammatory Disease Treatment Market Value (US$ Mn) and Y-o-Y, 2021-2028
FIG. 4 Global Ulcerative Colitis Segment Market Value (US$ Mn) By Region, 2013-2021
FIG. 5 Global Ulcerative Colitis Segment Market Value (US$ Mn) By Region, 2022-2028
FIG. 6 Global Ulcerative Colitis Segment Y-o-Y Growth Rate, By Region, 2021-2028
FIG. 7 Global Juvenile Rheumatoid Arthritis Segment Market Value (US$ Mn) By Region, 2013-2021
FIG. 8 Global Juvenile Rheumatoid Arthritis Segment Market Value (US$ Mn) By Region, 2022-2028
FIG. 9 Global Juvenile Rheumatoid Arthritis Segment Y-o-Y Growth Rate, By Region, 2021-2028
FIG. 10 Global Psoriatic Arthritis Segment Market Value (US$ Mn) By Region, 2013-2021
FIG. 11 Global Psoriatic Arthritis Segment Market Value (US$ Mn) By Region, 2022-2028
FIG. 12 Global Psoriatic Arthritis Segment Y-o-Y Growth Rate, By Region, 2021-2028
FIG. 13 Global Other Indications Segment Market Value (US$ Mn) By Region, 2013-2021
FIG. 14 Global Other Indications Segment Market Value (US$ Mn) By Region, 2022-2028
FIG. 15 Global Other Indications Segment Y-o-Y Growth Rate, By Region, 2021-2028
FIG. 16 Global Biologics Segment Market Value (US$ Mn) By Region, 2013-2021
FIG. 17 Global Biologics Segment Market Value (US$ Mn) By Region, 2022-2028
FIG. 18 Global Biologics Segment Y-o-Y Growth Rate, By Region, 2021-2028
FIG. 19 Global Organic Compounds Segment Market Value (US$ Mn) By Region, 2013-2021
FIG. 20 Global Organic Compounds Segment Market Value (US$ Mn) By Region, 2022-2028
FIG. 21 Global Organic Compounds Segment Y-o-Y Growth Rate, By Region, 2021-2028
FIG. 22 Global Injectables Segment Market Value (US$ Mn) By Region, 2013-2021
FIG. 23 Global Injectables Segment Market Value (US$ Mn) By Region, 2022-2028
FIG. 24 Global Injectables Segment Y-o-Y Growth Rate, By Region, 2021-2028
FIG. 25 Global Oral Segment Market Value (US$ Mn) By Region, 2013-2021
FIG. 26 Global Oral Segment Market Value (US$ Mn) By Region, 2022-2028
FIG. 27 Global Oral Segment Y-o-Y Growth Rate, By Region, 2021-2028
FIG. 28 Global Others Segment Market Value (US$ Mn) By Region, 2013-2021
FIG. 29 Global Others Segment Market Value (US$ Mn) By Region, 2022-2028
FIG. 30 Global Others Segment Y-o-Y Growth Rate, By Region, 2021-2028
FIG. 31 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2013-2021
FIG. 32 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2022-2028
FIG. 33 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2021-2028
FIG. 34 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2013-2021
FIG. 35 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2022-2028
FIG. 36 Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2021-2028
FIG. 37 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2013-2021
FIG. 38 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2022-2028
FIG. 39 Global Online Pharmacies Segment Y-o-Y Growth Rate, By Region, 2021-2028
FIG. 40 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2013-2021
FIG. 41 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2022-2028
FIG. 42 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2013-2021
FIG. 43 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2022-2028
FIG. 44 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2013-2021
FIG. 45 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2022-2028
FIG. 46 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2013-2021
FIG. 47 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2022-2028
FIG. 48 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2013-2021
FIG. 49 North America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2022-2028
FIG. 50 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2013-2021
FIG. 51 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2022-2028
FIG. 52 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2013-2021
FIG. 53 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2022-2028
FIG. 54 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2013-2021
FIG. 55 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2022-2028
FIG. 56 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2013-2021
FIG. 57 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2022-2028
FIG. 58 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2013-2021
FIG. 59 Latin America Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2022-2028
FIG. 60 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2013-2021
FIG. 61 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2022-2028
FIG. 62 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2013-2021
FIG. 63 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2022-2028
FIG. 64 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2013-2021
FIG. 65 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2022-2028
FIG. 66 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2013-2021
FIG. 67 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2022-2028
FIG. 68 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2013-2021
FIG. 69 Europe Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2022-2028
FIG. 70 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2013-2021
FIG. 71 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2022-2028
FIG. 72 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2013-2021
FIG. 73 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2022-2028
FIG. 74 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2013-2021
FIG. 75 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2022-2028
FIG. 76 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2013-2021
FIG. 77 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2022-2028
FIG. 78 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2013-2021
FIG. 79 Japan Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2022-2028
FIG. 80 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2013-2021
FIG. 81 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2022-2028
FIG. 82 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2013-2021
FIG. 83 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2022-2028
FIG. 84 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2013-2021
FIG. 85 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2022-2028
FIG. 86 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2013-2021
FIG. 87 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2022-2028
FIG. 88 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2013-2021
FIG. 89 APEJ Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2022-2028
FIG. 90 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2013-2021
FIG. 91 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Country 2022-2028
FIG. 92 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2013-2021
FIG. 93 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Indication 2022-2028
FIG. 94 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2013-2021
FIG. 95 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Drug Class 2022-2028
FIG. 96 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2013-2021
FIG. 97 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Mode of Administration 2022-2028
FIG. 98 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2013-2021
FIG. 99 MEA Rare Inflammatory Disease Treatment Market Value (US$ Mn), By Distribution Channel 2022-2028
